About this episode
The field of Microbiology continues to change. Organisms were primarily identified in the clinical laboratory by biochemical testing. Then MALDI-TOF came to the lab and was incorporated to the workflow. Now labs are bringing next-generation sequencing (NGS). What is NGS? How does it work? Have you heard of Nanopore technologies? In this episode Dr. Jose Alexander and Daniel Navas from Advent Health Orlando, join the podcast to talk about NGS. They brought it to their laboratory and discuss the whole process, including the validation, challenges and more.
Have any feedback or suggestions? Send those to [email protected]
Get every episode summarized
Each time Let's Talk Micro publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Let's Talk Micro
242: Microbiology & Infection Prevention: Partners in Crime
Let's Talk Micro
241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance?
Let's Talk Micro
240: CLSI M100 2026: Actualizaciones
Let's Talk Micro
239: Inside ASM Microbe 2026
Let's Talk Micro